Patient’s review after the course of treatment for hepatitis C

Review of the patient about the course of treatment of hepatitis with the transition to cirrhosis of the liver, chronic acalculous cholecystitis, using the ShorDiCell® technique

Video review of the patient

Woman, 34 years old

She has been ill since September 2010, when she was diagnosed for the first time: chronic viral hepatitis C. Medication (interferon therapy: pegasis 180 + kopegus 800) was conducted between September 2010 and November 2011.

In 2012, hospitalized with complaints of a periodic increase of body temperature to 37.5 ° C, bleeding gums, bloating.

Diagnosed: chronic viral hepatitis (HCV) with a transition to cirrhosis of the liver, chronic acalculous cholecystitis.

The treating physician recommends cell therapy. After passing the standard course of injections of autologous stem cells, according to the patient, side effects of interferon therapy have passed, overall well-being improved.

During 2013, a number of tests were performed, as well as elastometry (fibroscanaging) of the liver, which did not reveal the presence of the hepatitis C virus.

Biopro Stem Technology company constantly participates in the development and clinical use of new therapies using human mesenchymal stem cells.

More information about new methods of treatment you can find out by contacting us. Contact details are on the Contacts page.